Table 2 Primary process (adherence) outcomes, source of data, measurement sequence, and definitions

Timely and appropriate screening and management of anemia during pregnancy

Case records data from the PHC in the eRegistry

Registrations continuously at point of care, data export to the trial monthly

Proportion of women attending ANC who receive:

1. anemia screening at booking, and

2. screening at any ANC visits at 24 and 36 weeks if no anemia detected, and

3. rescreening after 1 month if mild or moderate anemia is detected, and

4. referred to high-risk clinic if refractory mild or moderate anemia is detected, and

5. referred to hospital if severe anemia is detected.

Timely and appropriate screening and management of hypertension in pregnancy

Case records data from the PHC in the eRegistry

Registrations continuously at point of care, data export to the trial monthly

Proportion of women attending ANC who receive:

1. blood pressure measurement at booking visit, and

2. blood pressure measurement at every ANC visit, and

3. appropriate laboratory tests for mild hypertension, and

4. referred to high-risk clinic hospital for chronic or gestational hypertension, and

5. referred to hospital for hypertension with proteinuria or signs of eclampsia.

Timely and appropriate screening and management of abnormal fetal growth

Case records data from the PHC in the eRegistry

Registrations continuously at point of care, data export to the trial monthly

Proportion of women attending ANC who receive:

1. first fundal height measurement at 16–20 weeks, and

2. fetal growth monitoring at every ANC visit, and

3. referred to ultrasound if discrepancy between fundal height and gestational age, and

4. referred to high-risk clinic if ultrasound confirmed fetal growth restriction.

Timely and appropriate screening and management of diabetes in pregnancy

Case records data from the PHC in the eRegistry

Registrations continuously at point of care, data export to the trial monthly

Proportion of women attending ANC who receive:

1. diabetes screening at booking, and

2. screening with random blood sugar test at 24–28 weeks, and

3. referred to high-risk clinic if random blood sugar test or glucose challenge test ≥ 140 mg/dl.